Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

New tools for antigen delivery to the MHC class I pathway.

Morón G, Dadaglio G, Leclerc C.

Trends Immunol. 2004 Feb;25(2):92-7. Review.

PMID:
15102368
2.

Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle.

Buddle BM, McCarthy AR, Ryan TJ, Pollock JM, Vordermeier HM, Hewinson RG, Andersen P, de Lisle GW.

Vet Rec. 2003 Nov 15;153(20):615-20.

PMID:
14653340
3.

Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.

Dadaglio G, Morel S, Bauche C, Moukrim Z, Lemonnier FA, Van Den Eynde BJ, Ladant D, Leclerc C.

Int Immunol. 2003 Dec;15(12):1423-30.

PMID:
14645151
4.

Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: Role of toxin acylation and identification of the main integrin interaction domain.

El-Azami-El-Idrissi M, Bauche C, Loucka J, Osicka R, Sebo P, Ladant D, Leclerc C.

J Biol Chem. 2003 Oct 3;278(40):38514-21.

5.

Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.

Hewinson RG, Vordermeier HM, Buddle BM.

Tuberculosis (Edinb). 2003;83(1-3):119-30. Review.

PMID:
12758201
7.

In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells.

Guermonprez P, Fayolle C, Rojas MJ, Rescigno M, Ladant D, Leclerc C.

Eur J Immunol. 2002 Nov;32(11):3071-81.

8.
9.
10.

Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.

Fayolle C, Osickova A, Osicka R, Henry T, Rojas MJ, Saron MF, Sebo P, Leclerc C.

J Virol. 2001 Aug;75(16):7330-8.

11.

The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18).

Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, Ladant D, Leclerc C.

J Exp Med. 2001 May 7;193(9):1035-44.

12.

Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle.

Vordermeier HM, Whelan A, Cockle PJ, Farrant L, Palmer N, Hewinson RG.

Clin Diagn Lab Immunol. 2001 May;8(3):571-8.

13.

Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test.

Vordermeier HM, Cockle PJ, Whelan AO, Rhodes S, Chambers MA, Clifford D, Huygen K, Tascon R, Lowrie D, Colston MJ, Hewinson RG.

Vaccine. 2000 Dec 8;19(9-10):1246-55.

PMID:
11137264
14.

Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells.

Guermonprez P, Fayolle C, Karimova G, Ullmann A, Leclerc C, Ladant D.

Methods Enzymol. 2000;326:527-42. No abstract available.

PMID:
11036662
15.

Assessment of defined antigens for the diagnosis of bovine tuberculosis in skin test-reactor cattle.

Pollock JM, Girvin RM, Lightbody KA, Clements RA, Neill SD, Buddle BM, Andersen P.

Vet Rec. 2000 Jun 3;146(23):659-65.

PMID:
10883854
16.
18.

In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8(+) T-cell epitope.

Sebo P, Moukrim Z, Kalhous M, Schaft N, Dadaglio G, Sheshko V, Fayolle C, Leclerc C.

FEMS Immunol Med Microbiol. 1999 Nov;26(2):167-73.

19.

Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide.

Wilkinson KA, Hudecz F, Vordermeier HM, Ivanyi J, Wilkinson RJ.

Eur J Immunol. 1999 Sep;29(9):2788-96.

20.

Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle.

Vordermeier HM, Cockle PC, Whelan A, Rhodes S, Palmer N, Bakker D, Hewinson RG.

Clin Diagn Lab Immunol. 1999 Sep;6(5):675-82.

Items per page

Supplemental Content

Support Center